日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naïve Cancer Patients

一项评估雷莫司琼、阿瑞吡坦和地塞米松预防未接受过化疗的癌症患者顺铂引起的恶心和呕吐疗效的 II 期研究

Jang, Geundoo; Song, Hun Ho; Park, Keon Uk; Kim, Hyeong Su; Choi, Dae Ro; Kwon, Jung Hye; Kim, Ho Young; Han, Boram; Kim, Jung Han; Jung, Joo Young; Kim, Hyo Jung; Zang, Dae Young

Predictors of high score patient-reported barriers to controlling cancer pain: a preliminary report

预测患者自述癌症疼痛控制障碍高分因素的初步报告

Kwon, Jung Hye; Oh, Sung Yong; Chisholm, Gary; Lee, Jung-Ae; Lee, Jae Jin; Park, Keon Woo; Nam, Seung-Hyun; Song, Hun Ho; Lee, Keehyun; Zang, Dae Young; Kim, Ho Young; Choi, Dae Ro; Kim, Hyo Jung; Kim, Jung Han; Jung, Joo Young; Jang, Geundoo; Kim, Hyeong Su; Won, Ji Yun; Bruera, Eduardo

A phase I/II study of bortezomib plus CHOP every 2 weeks (CHOP-14) in patients with advanced-stage diffuse large B-cell lymphomas

硼替佐米联合 CHOP 方案每 2 周一次(CHOP-14)治疗晚期弥漫性大 B 细胞淋巴瘤患者的 I/II 期研究

Kim, Jeong Eun; Yoon, Dok Hyun; Jang, Geundoo; Lee, Dae Ho; Kim, Shin; Park, Chan-Sik; Huh, Jooryung; Kim, Won Seog; Park, Jinny; Lee, Jae Hoon; Lee, Soon Il; Suh, Cheolwon

Autologous stem cell transplantation for diffuse large B-cell lymphoma with residual extranodal involvement

自体干细胞移植治疗伴有残余结外受累的弥漫性大B细胞淋巴瘤

Ko, Ock Bae; Jang, Geundoo; Kim, Shin; Huh, Jooryung; Suh, Cheolwon

Prognostic factors in non-Hodgkin's lymphoma patients treated by autologous stem cell transplantation: a single center experience

自体干细胞移植治疗非霍奇金淋巴瘤患者的预后因素:单中心经验

Suh, Cheolwon; Kim, Sang Hee; Kim, Hyo Jung; Jang, Geundoo; Kim, Eun Kyung; Ko, Ok Bae; Kim, Shin; Sohn, Hee Jung; Lee, Jung Shin; Kim, M Wookun; Huh, Jooryung